SCHEMBL24935618

SCHEMBL24935618

CC(C)CCCC(=O)NCCCNC(=O)COC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.43
LMNA P02545 3/20 0.42
PKM P14618 1/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.41
CNR1 P21554 2/20 0.40
NAMPT P43490 1/20 0.38
CNR2 P34972 1/20 0.38
CYP3A4 P08684 2/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 2/20 0.37
CASP2 P42575 1/20 0.36
FAAH O00519 2/20 0.36
ATM Q13315 1/20 0.36
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25063763 0.97 HPGD (0.43) HPGDLMNAPKMTSHRALDH1A1
SCHEMBL25063750 0.95 ALDH1A1 (0.46) HPGDLMNAPKMTSHRALDH1A1
SCHEMBL24935605 0.92 ALDH1A1 (0.46) HPGDLMNAPKMTSHRALDH1A1
SCHEMBL14240965 0.90 ALDH1A1 (0.41) HPGDLMNAPKMALDH1A1KMT2A
SCHEMBL16213686 0.88 FAAH (0.41) HPGDLMNAPKMALDH1A1KMT2A
SCHEMBL22872813 0.87 FAAH (0.44) HPGDLMNAALDH1A1NAMPTKMT2A
SCHEMBL26691656 0.87 FAAH (0.44) HPGDLMNAALDH1A1NAMPTKMT2A
SCHEMBL24935539 0.82 TSHR (0.51) HPGDLMNAPKMTSHRALDH1A1
SCHEMBL26700969 0.81 HPGD (0.50) HPGDLMNAPKMTSHRALDH1A1
SCHEMBL25849373 0.81 ALDH1A1 (0.51) HPGDLMNATSHRALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054270-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) 2023-02-23 US disclosed
EP-4119546-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Suzhou Kintor Pharmaceuticals, Inc. (CN) 2023-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230054270-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF AR, SHBG, NR5A1 HPGD 3056/4885LMNA 3694/4885PKM 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.